Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GeNeuro Innovation SAS
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signature of an informed consent;
Male or female between 18 and 60 years of age;
Patients with PPMS (Revised McDonald criteria 2010) or patients with SPMS or CIS or patients with RRMS (Revised McDonald criteria 2010) ideally without IFN beta therapy at the T0 visit for RRMS patient only.
You may not be if
Positive serology for hepatitis B or C or HIV;
Acute infection at inclusion;
Severe psychiatric disorder;
Autoimmune disease other than MS;
Pregnancy or breastfeeding;
Heavy smokers i.e. more than 10 cigarettes per day;
History of alcohol or drug abuse in the last 3 years;
Participation in a clinical trial (within the last 3 months).
Clareo Health | Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
